121 related articles for article (PubMed ID: 6762740)
1. Cis-dichlorodiammineplatinum (II), VP 16-213, and prednisone (DVP regimen) in the treatment of pretreated advanced malignant lymphomas.
Fosser VP; Salvagno L; Segati R; Pappagallo GL; Ferrazzi E; Sileni VC; Fiorentino MV
Tumori; 1982 Dec; 68(6):515-8. PubMed ID: 6762740
[TBL] [Abstract][Full Text] [Related]
2. Cis-dichlorodiammineplatinum (cis-platinum) and etoposide (VP-16) in malignant lymphoma--an effective salvage regimen.
Judson IR; Wiltshaw E
Cancer Chemother Pharmacol; 1985; 14(3):258-61. PubMed ID: 4039635
[TBL] [Abstract][Full Text] [Related]
3. Cis-dichlorodiammineplatinum (II) (cis-platinum) and etoposide for patients with refractory lymphomas.
von Heyden HW; Scherpe A; Nagel GA
Cancer Treat Rev; 1982 Jun; 9 Suppl():45-52. PubMed ID: 6889921
[No Abstract] [Full Text] [Related]
4. Combination chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) for non-Hodgkin's lymphomas with unfavorable histology: preliminary results.
Comella P; Abate G; Comella G; Bruni GS; Zarrilli D; Pergola M
Tumori; 1980 Dec; 66(6):749-56. PubMed ID: 7233568
[TBL] [Abstract][Full Text] [Related]
5. A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma.
Salvagno L; Contu A; Bianco A; Endrizzi L; Schintu GM; Olmeo N; Aversa SM; Chiarion-Sileni V; Sorarù M; Fiorentino MV
Ann Oncol; 1992 Dec; 3(10):833-7. PubMed ID: 1286045
[TBL] [Abstract][Full Text] [Related]
6. cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung.
Sierocki JS; Hilaris BS; Hopfan S; Martini N; Barton D; Golbey RB; Wittes RE
Cancer Treat Rep; 1979; 63(9-10):1593-7. PubMed ID: 227598
[TBL] [Abstract][Full Text] [Related]
7. Comparative trial of two teniposide-based combination chemotherapy regimens for the treatment of advanced malignant lymphomas.
O'Connell MJ; Anderson J; Merrill JM; Bennett JM; Glick JH; Berard CW; Neiman RS; Brodovsky HS
Cancer Treat Rep; 1982 Dec; 66(12):2021-5. PubMed ID: 6814757
[TBL] [Abstract][Full Text] [Related]
8. Etoposide (VP-16-213) and cis-dichlorodiammineplatinum (DDP) in advanced breast carcinoma resistant to previous chemotherapy.
Athanassiades P; Bacoyiannes H; Kontoyiannes D
Chemioterapia; 1986 Apr; 5(2):125-7. PubMed ID: 3518965
[TBL] [Abstract][Full Text] [Related]
9. Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancer.
Goldhirsch A; Joss RA; Cavalli F; Sonntag RW; Brunner KW
Med Pediatr Oncol; 1981; 9(3):205-8. PubMed ID: 6264280
[TBL] [Abstract][Full Text] [Related]
10. VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.
Hansen MM; Bloomfield CD; Jørgensen J; Ersbøll J; Pedersen-Bjergaard J; Blom J; Nissen NI
Cancer Treat Rep; 1980; 64(10-11):1135-7. PubMed ID: 7459900
[TBL] [Abstract][Full Text] [Related]
11. VP-16 in the treatment of malignant lymphomas: a report from the Swiss Group for Clinical Cancer Research (SAKK).
Cavalli F
Semin Oncol; 1985 Mar; 12(1 Suppl 2):33-6. PubMed ID: 3975656
[TBL] [Abstract][Full Text] [Related]
12. Phase III trial of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) versus cisplatin, etoposide, bleomycin and prednisone (CisEBP) for the treatment of advanced non-Hodgkin's lymphoma of high grade malignancy. The Danish Lymphoma Study Group.
Andersen J; Thorling K; Bentzen SM; Brincker H; Christensen BE; Pedersen M
Acta Oncol; 1990; 29(8):995-9. PubMed ID: 1703769
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
[TBL] [Abstract][Full Text] [Related]
14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
15. Intermediate and high grade malignant non-Hodgkin's lymphomas: preliminary results using a new combination regimen (EVE-COPEM).
Battista C; Panza N; Chiurazzi B; Iodice G; Esposito G; Cocorocchio E; Bevilacqua N; Pacilio G
Biomed Pharmacother; 1993; 47(4):145-54. PubMed ID: 8018826
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of cis-dichlorodiammineplatinum(II) in advanced malignant lymphoma and small cell lung cancer: preliminary results.
Cavalli F; Jungi WF; Sonntag RW; Nissen NI; Holland JF
Cancer Treat Rep; 1979; 63(9-10):1599-603. PubMed ID: 227599
[TBL] [Abstract][Full Text] [Related]
17. Etoposide as a single agent in relapsed advanced lymphomas. A phase II study.
Taylor RE; McElwain TJ; Barrett A; Peckham MJ
Cancer Chemother Pharmacol; 1982; 7(2-3):175-7. PubMed ID: 7083459
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of cis-dichlorodiammineplatinum (II) in advanced malignant lymphoma: a study of the cancer and acute leukemia group B.
Cavalli F; Jungi WF; Nissen NI; Pajak TF; Coleman M; Holland JF
Cancer; 1981 Nov; 48(9):1927-30. PubMed ID: 7197582
[TBL] [Abstract][Full Text] [Related]
19. Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group Study.
Weick JK; Jones SE; Haut A; Fisher R; Dixon D
Cancer Treat Rep; 1981; 65(7-8):611-4. PubMed ID: 6166373
[TBL] [Abstract][Full Text] [Related]
20. The rationale of therapy with mitoxantrone in non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Co-operative Study Group, (NHLCSG) Italy.
Chisesi T
Leuk Lymphoma; 1993 Jan; 9(1-2):63-9. PubMed ID: 8477203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
